Correlation Between Oncternal Therapeutics and Arch Capital
Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Arch Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Arch Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncternal Therapeutics and Arch Capital Group, you can compare the effects of market volatilities on Oncternal Therapeutics and Arch Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Arch Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Arch Capital.
Diversification Opportunities for Oncternal Therapeutics and Arch Capital
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Oncternal and Arch is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Arch Capital Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Capital Group and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Arch Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Capital Group has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Arch Capital go up and down completely randomly.
Pair Corralation between Oncternal Therapeutics and Arch Capital
Given the investment horizon of 90 days Oncternal Therapeutics is expected to generate 1.88 times less return on investment than Arch Capital. In addition to that, Oncternal Therapeutics is 2.54 times more volatile than Arch Capital Group. It trades about 0.06 of its total potential returns per unit of risk. Arch Capital Group is currently generating about 0.27 per unit of volatility. If you would invest 9,714 in Arch Capital Group on March 5, 2024 and sell it today you would earn a total of 549.00 from holding Arch Capital Group or generate 5.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Oncternal Therapeutics vs. Arch Capital Group
Performance |
Timeline |
Oncternal Therapeutics |
Arch Capital Group |
Oncternal Therapeutics and Arch Capital Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncternal Therapeutics and Arch Capital
The main advantage of trading using opposite Oncternal Therapeutics and Arch Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Arch Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Capital will offset losses from the drop in Arch Capital's long position.Oncternal Therapeutics vs. CytomX Therapeutics | Oncternal Therapeutics vs. Assembly Biosciences | Oncternal Therapeutics vs. Instil Bio | Oncternal Therapeutics vs. Nuvation Bio |
Arch Capital vs. Axa Equitable Holdings | Arch Capital vs. American International Group | Arch Capital vs. Sun Life Financial | Arch Capital vs. Hartford Financial Services |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |